Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

IAI vs IHF: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

IHF Wins Head-to-Head Institutional Verdict (0–0 across 6 Pillars · 3–0 Matrix Metrics)

IHF Overall Winner 6-Pillar Tally: IAI 0 – 0 IHF (6 Tie) Matrix Metrics: IAI 0 – 3 IHF

As of Nov 16, 2026, iShares U.S. Healthcare Providers ETF (IHF) is the stronger overall head-to-head candidate over iShares U.S. Broker-Dealers & Securities Exchanges ETF (IAI) in the Tradestie Institutional Equity Comparison Engine, winning 3–0 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). IAI carries a Unified Composite Score of 43.5/100 (HOLD) at $180.00 (N/M Forward P/E, N/A operating margin), whereas IHF carries 47.8/100 (HOLD) at $60.98 (N/M Forward P/E, N/A operating margin).

  • Technical & Structure Timing Caution: IAI is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 48.9); meanwhile IHF trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 60.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About IAI vs IHF
IAI NYSE Arca
iShares U.S. Broker-Dealers & Securities Exchanges ETF
Institutional Equity
$180.00
-1.69% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.94β · 25% Vol
Unified Composite Score
43.5 / 100 HOLD
Tech 44.0 Fund 48.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -2.7%) with fading momentum, RSI 49
RSI-14: 48.9 · SMA20: $180.09 · SMA50: $180.67
IHF NYSE Arca Head-to-Head Winner
iShares U.S. Healthcare Providers ETF
Institutional Equity
$60.98
+0.94% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.30β · 18% Vol
Unified Composite Score
47.8 / 100 HOLD
Tech 36.0 Fund 47.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (2.1% over 20 days), RSI 61
RSI-14: 60.9 · SMA20: $60.03 · SMA50: $57.89

6-Pillar Scorecard Institutional Category Breakdown (IAI 0 – 0 IHF)

Columns: Metric · IAI · IHF
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale Tie
Revenue Growth (YoY) N/A N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) N/A N/A
Market Cap N/A N/A
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin N/A N/A
Net Profit Margin N/A N/A
Return on Equity (ROE) N/A N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 21.9% (12th %ile) 18.0% (<1st %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Distribution NEUTRAL · Markup
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: IAI (0) vs IHF (3)
Institutional Metric IAI IHF Criterion Row Edge
Market Capitalization
Scale
N/A N/A Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A N/A Higher Growth Tie
Operating Margin (TTM)
Profitability
N/A N/A Higher Margin Tie
Net Profit Margin
Profitability
N/A N/A Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
N/A N/A Higher ROE Tie
52-Week Range Position
Momentum
55% ($158–$198) 97% ($41–$62) Stronger Trend IHF
Beta / 30D Volatility
Risk Regime
0.94β · 25% Vol 0.30β · 18% Vol Lower Realized Risk IHF
Unified Institutional Score
Composite Signal
43.5 / 100 (HOLD) 47.8 / 100 (HOLD) Higher Composite IHF
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon IHF +1.62 pp
IAI: +2.35% · IHF: +3.97%
3M Horizon IHF +13.43 pp
IAI: -5.46% · IHF: +7.97%
6M Horizon IHF +19.08 pp
IAI: +0.58% · IHF: +19.66%
1Y Horizon IHF +23.53 pp
IAI: +2.83% · IHF: +26.36%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IAI vs IHF. Trailing 12-month operating profitability (IAI N/A vs IHF N/A) and valuation multiples (IAI N/M vs IHF N/M Forward P/E) are benchmarked directly in Pillar 4 below.

IAI ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
IHF ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
IAI UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 21.9%
IV Percentile 12th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact IAI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
IHF UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 18.0%
IV Percentile <1st %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact IHF Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
IAI Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
IHF Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ IAI vs IHF Key Questions & Quantitative Answers

As of Nov 16, 2026, iShares U.S. Healthcare Providers ETF (IHF) is the stronger overall head-to-head candidate over iShares U.S. Broker-Dealers & Securities Exchanges ETF (IAI) in the Tradestie Institutional Equity Comparison Engine, winning 3–0 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). IAI carries a Unified Composite Score of 43.5/100 (HOLD) at $180.00 (N/M Forward P/E, N/A operating margin), whereas IHF carries 47.8/100 (HOLD) at $60.98 (N/M Forward P/E, N/A operating margin). Technical & Structure Timing Caution: IAI is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 48.9); meanwhile IHF trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 60.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

IAI and IHF split Growth & Scale metrics: IAI posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with IHF at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, IAI generates N/A in USD-normalized revenue versus N/A for IHF. In operating R&D and SG&A reinvestment, IAI deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for IHF.

IAI and IHF trade at balanced relative valuation multiples. IAI trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas IHF trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against IAI (N/A ROE) versus IHF (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, IAI carries 21.9% implied volatility (12th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.94β · 25% Vol realized risk). By comparison, IHF carries 18.0% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.30β · 18% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

iShares U.S. Broker-Dealers & Securities Exchanges ETF (IAI) Research Suite

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.